Clinical trials
MG clinical trials
Below are recruiting mg clinical trials, each written for real people, not researchers. We’re tracking 966 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07219615RecruitingPhase 2
Study of Ritlecitinib for Chronic Hives Not Helped by Antihistamines
This study is testing an experimental daily pill called ritlecitinib for adults whose chronic hives don’t go away with standard antihistamines. It may be a new option if your hives are active and you are not on omalizumab or are willing to stop it for several months.
Phoenix, ArizonaAges 18 years+ - NCT07279688RecruitingPhase 3
Baricitinib plus steroids for polymyalgia rheumatica
This trial tests if adding baricitinib (a pill that calms inflammation) to standard steroids works better than steroids alone for people with polymyalgia rheumatica. It aims to improve symptoms and reduce steroid side effects.
Aix-en-ProvenceAges 50 years+ - NCT07423533RecruitingPhase 2
GenSci120 injection for moderate to severe rheumatoid arthritis
This trial tests a new injection called GenSci120 for people with moderate to severe rheumatoid arthritis who haven't improved enough after trying at least one standard arthritis medication. The goal is to see if this treatment can help reduce joint pain and swelling.
Beijing, Beijing MunicipalityAges 18–70 - NCT07487714Enrolling by invitationPhase 4
Comparing amiodarone doses for paroxysmal AF
This study compares three different daily doses of the heart rhythm medication amiodarone to find the most effective one for preventing episodes of paroxysmal atrial fibrillation. Participants will take one of three doses (100, 200, or 400 mg) for up to 12 months, and the study will monitor how well each dose controls the irregular heartbeat.
TomskAges 18–80 - NCT05441475Enrolling by invitationPhase 2
Trial for advanced liver cancer using ABSK-011 plus atezolizumab
This Phase 2 study tests ABSK-011 combined with either atezolizumab or the usual care in people with advanced or unresectable liver cancer. It aims to see if the treatment helps shrink tumors and control the cancer when standard options aren’t working or can’t be used.
Hubei, Shanghai MunicipalityAges 18 years+ - NCT07614776RecruitingPhase 3
New Eye Injection Treatment for Age-Related Macular Degeneration
This study tests whether a new eye injection called ABP 938 works as well as or better than the current standard treatment (Eylea) for wet age-related macular degeneration—a condition that causes vision loss in the center of your sight. You would receive injections into your eye every month for a year.
Fullerton, CaliforniaAges 50 years+ - NCT06687551RecruitingPhase 4
Testing lower doses of JAK inhibitors for rheumatoid arthritis
This study tests whether people with rheumatoid arthritis whose disease is well controlled can safely take a lower dose of their JAK inhibitor medication. It aims to see if reducing the dose still keeps inflammation down and prevents flare-ups.
Toulouse, OccitanieAges 18–65 - NCT05762107RecruitingPhase 2
Drug ZT-01 to reduce low blood sugar at night
This Phase 2 study tests ZT-01 to help prevent night-time low blood sugar (hypoglycemia) in people with type 1 diabetes. It may help if you’ve had low blood sugar during sleep or are at high risk based on recent glucose monitoring.
Birmingham, AlabamaAges 18–75 - NCT05626621RecruitingPhase 4
Nasal rinse with allergy sprays vs regular nasal sprays
This study compares two types of allergy-related nasal treatment: a rinse with azelastine and mometasone versus standard nasal sprays. It aims to see which approach works better for people with long-term (chronic) rhinitis over 6 months.
Evanston, IllinoisAges 18 years+ - NCT05513365RecruitingPhase 2
Dutasteride added to anti-androgen treatment for salivary cancer
This Phase 2 trial studies whether adding dutasteride to standard anti-androgen therapy can shrink or slow an advanced salivary gland cancer. It is for cancers that test “androgen receptor (AR) positive,” meaning they may respond to medicines that block male-hormone signals.
Nijmegen, GelderlandAges 18 years+ - NCT06803030RecruitingPhase 3
Study of three drugs for ureteral stent discomfort
This trial is testing three different medicines to see if they can reduce common symptoms like pain and frequent urination caused by a ureteral stent placed after kidney stone surgery. If you are between 19 and 80 years old and had a stent placed during ureteroscopy, you may be able to join.
Kathmandu, BagmatiAges 18–80 - NCT07409103RecruitingPhase 2
Testing ELV001 for active rheumatoid arthritis
This study tests a new medication, ELV001, for people with active rheumatoid arthritis who haven't improved enough with methotrexate and a TNF inhibitor. The goal is to see if different doses of ELV001 are safe and can help reduce joint pain and swelling.
Gilbert, ArizonaAges 18–75 - NCT06303128RecruitingPhase 3
Testing penicillin allergy with one vs. two oral doses
This trial compares a single dose versus two doses of a penicillin-like drug to see if people who think they are allergic to penicillin can safely be told they are not allergic. It is for people with a low-risk penicillin allergy who want to find out if they can use these antibiotics in the future.
Lubbock, TexasAges 18–89 - NCT06967753RecruitingPhase 4
Switching to a two-drug HIV regimen for transgender women
This trial tests if switching to a two-drug combination of dolutegravir and lamivudine is safe and effective for transgender women who already have undetectable HIV levels on a three-drug regimen. It aims to simplify treatment and reduce side effects.
Buenos Aires, Buenos Aires F.D.Ages 18 years+ - NCT06767800RecruitingPhase 2
Study of TQB2102 with immunotherapy for HER2-positive gastroesophageal cancer
This trial tests a new combination of drugs (TQB2102, benmelstobart, and pembrolizumab) with or without chemotherapy for people with HER2-positive gastroesophageal cancer that cannot be removed by surgery or has spread. It aims to see if this combination is more effective than current treatments.
Fuyang, AnhuiAges 18–75 - NCT07433387RecruitingPhase 1/Phase 2
Study of a new HIV drug for people not on treatment
This trial tests a new injectable treatment called LP-98 for people with HIV who have never taken HIV medications before. It aims to see if the drug is safe and can help lower the virus in your body.
Tianjin, Tianjin MunicipalityAges 18–65 - NCT07372625RecruitingPhase 1
How rezatapopt affects common drugs in advanced solid tumors with TP53 Y220C mutation
This trial tests how rezatapopt changes the way your body processes four common medicines (metformin, rosuvastatin, repaglinide, and midazolam) in people with advanced solid tumors that have a specific TP53 Y220C gene change. It helps doctors understand the right dose for future patients.
Denver, ColoradoAges 18 years+ - NCT05692999RecruitingPhase 3
Maintenance pembrolizumab dose study for non-squamous lung cancer
This Phase 3 trial tests two maintenance schedules (“usual” dose versus a lower dose) of pembrolizumab after your initial chemotherapy with pembrolizumab. It aims to see if the lower dose works well enough to control cancer while possibly reducing side effects.
NamurAges 18 years+ - NCT07016269RecruitingPhase 4
Study of CnU Cap. 500 mg for Biliary Dyspepsia
This trial tests a medication called CnU Cap. 500 mg to see if it helps people with biliary dyspepsia, a type of upper belly pain caused by the gallbladder or bile ducts. It may help if you have episodes of steady pain in the upper right belly that last at least 30 minutes and disrupt your daily life.
Ansan, Gyeonggi-doAges 19 years+ - NCT07402369RecruitingPhase 2
Testing CMS-D002 for heavy bleeding from uterine fibroids
This trial tests a capsule called CMS-D002 for heavy periods caused by uterine fibroids. It might help reduce your bleeding if you have fibroids at least 2 cm in size, regular cycles, and are between 18 and 50.
Beijing, Beijing MunicipalityAges 18–50 - NCT07382167RecruitingPhase 3
Study of Tenapanor for Chronic Constipation in Adults
This study tests an investigational drug called tenapanor for people with chronic idiopathic constipation (constipation with no clear cause). It aims to see if the drug can safely improve bowel movements in adults.
Foley, AlabamaAges 18–80 - NCT07072195RecruitingPhase 2
A study of AMC6156 for people with muscle loss
This trial tests an investigational drug called AMC6156 to see if it can help improve muscle mass and strength in older adults with sarcopenia (age-related muscle loss). Participants will also follow exercise and nutrition guidance.
Seongnam-si, Gyeonggi-doAges 65 years+ - NCT07693426RecruitingPhase 1
Study of efsubaglutide alfa for obese teenagers
This trial tests an injection called efsubaglutide alfa to help obese teenagers lose weight. It requires following diet and exercise advice for at least 3 months before starting.
Beijing, Beijing MunicipalityAges 12–17 - NCT06972056RecruitingPhase 4
Comparing migraine prevention drugs: atogepant, propranolol, topiramate
This study compares three common migraine prevention medications to see which works best. You might be able to join if you have migraines at least 4 days a month and haven't taken these specific drugs before.
Flagstaff, ArizonaAges 18–70
Hear when a new MG trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for mg?
- Yes. Clin2 currently lists 966 recruiting mg studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a mg trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a mg trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.